Apimeds Pharmaceuticals US, Inc.
Clinical-stage biopharma developing a bee venom drug and AI digital treasury solutions.
APUS | US
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- 100 MATAWAN RD, 7747 MATAWAN
- Website:
- https://www.apimedsus.com/
- Sector:
- Manufacturing
Description
Apimeds Pharmaceuticals US, Inc. is a clinical-stage biopharmaceutical company focused on developing its lead product candidate, Apitox. This non-opioid, biologic drug is derived from bee venom and is intended for intradermal administration to treat pain associated with osteoarthritis of the knee. Following a merger with MindWave, the company has integrated its biotechnology development with a focus on AI-driven digital treasury and yield generation solutions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Apimeds Pharmaceuticals US, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Apimeds Pharmaceuticals US, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Apimeds Pharmaceuticals US, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
